Clinical Trials Logo

Uterine Cervical Neoplasms clinical trials

View clinical trials related to Uterine Cervical Neoplasms.

Filter by:

NCT ID: NCT00526370 Completed - Clinical trials for Uterine Cervical Neoplasms

Expression of Oncogenic Human Papillomavirus E6/E7 Protein in Tampon Self-Tests

Start date: August 2007
Phase: Phase 0
Study type: Observational

The purpose of this study is to examine for HPV E6/E7 mRNA in tampon self-tests, and compare with the cytological and histological diagnoses. Study Hypothesis: Expression of HPV E6/E7 mRNA in Tampon self-tests are a suitable alternative to the routine cervical smear.

NCT ID: NCT00522223 Completed - Cervical Cancer Clinical Trials

Sexual Functioning in Cervical Cancer Survivors

Start date: September 10, 2002
Phase:
Study type: Observational

Objectives: Primary Objectives: To assess the entire range of sexual functioning (desire, arousal, orgasmic capacity, dyspareunia, and sexual satisfaction) over the course of treatment and early follow-up in patients with local and locally advanced cervical cancer; To assess general cancer-related QOL over the course of treatment and early follow-up in patients with local and locally advanced cervical cancer; To characterize the relationship between sexual dysfunction and overall cancer-related QOL over time; and To identify factors that may predict better sexual function outcomes in patients treated for cervical cancer. Secondary Objectives: Describe vaginal changes objectively via measurement of vaginal length. Demonstrate reliability of the vaginal length instrument and its applicability to future studies.

NCT ID: NCT00520598 Completed - Cervical Cancer Clinical Trials

Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)

Start date: October 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and immunogenicity of V505 in comparison to GARDASIL (TM)

NCT ID: NCT00519272 Terminated - Cervical Cancer Clinical Trials

A Prospective Study Examining the Barriers to Care for Harris County Cervical Cancer Patients

Start date: July 21, 2006
Phase:
Study type: Observational

The goal of this behavioral research study is to look at the reasons that may prevent women from getting early treatment for their cervical cancer.

NCT ID: NCT00518388 Completed - Epidemiology Clinical Trials

Perceptions of Cervical Cancer Among Asian Americans

Start date: August 2007
Phase: N/A
Study type: Observational

The goal of this research study is to learn about the beliefs, practices, and knowledge about cervical cancer among Asian American young adults. Researchers want to develop materials that will educate Asian Americans about cervical cancer and encourage them to get screened for this disease.

NCT ID: NCT00518193 Terminated - Cervix Cancer Clinical Trials

Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix

ERBUS
Start date: April 2007
Phase: Phase 2
Study type: Interventional

The efficacy of chimiotherapy in cervix epithelial cancer is low even with the association cisplatine - topotecan . News thérapeutics are needed in the goal of increase the survival and quality of life in patients with cervix cancer. Cetuximab has shown the potentialisation on the efficacy of cisplatine and irinotecan. Cisplatine and topotecan have shown an efficacy in cervix cancer. Cetuximab is well tolerate. Many clinical trials shown the faisability of the association of cetuximab and cisplatine in cancer. Many clinical trials have shown the faisability of association of cetuximab and irinotecan in colorectals metastatiques cancers .

NCT ID: NCT00517309 Completed - Cervical Cancer Clinical Trials

Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED)

FUTURE
Start date: December 28, 2001
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to test the safety of HPV Vaccine in Women

NCT ID: NCT00513123 Completed - Cervical Cancer Clinical Trials

Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia

Start date: September 2002
Phase: N/A
Study type: Observational

The overall objective of this study is to identify potential improvements for a noninvasive method of diagnosing dysplasia and neoplasia in the cervix using digital colposcopy for colposcopy for fluorescence spectroscopy. Other Objectives: - To measure digital fluorescence and reflectance images in vivo of sites in the human cervix. - To evaluate the effect of acetic acid in the image contrast obtained. - Compare the device performance to colposcopy and pathologic analysis of tissue removed at colposcopy.

NCT ID: NCT00512551 Completed - Cervical Cancer Clinical Trials

DNA Array Analysis of Patients With Cervical Cancer

Start date: June 20, 2000
Phase: N/A
Study type: Observational

The goal of this clinical research study is to find out if the expression of certain genes is linked with the response of cervical cancer to radiation. Researchers will study a large number of genes located in tumor material to learn this information.

NCT ID: NCT00511615 Completed - Cervical Cancer Clinical Trials

Molecular Imaging for Detection of Cervical Intraepithelial Neoplasia

Start date: March 2005
Phase: N/A
Study type: Observational

The hypothesis of this research project is that topical application of the anti-EGFR or anti-E6/E7 contrast agents followed by optical imaging will yield images that reflect spatial variations in expression that correlate with the presence of cervical precancer. To gather feasibility data the investigators will: 1. Obtain cervical specimens from women with high grade squamous intraepithelial lesions (HGSILs) being treated with the loop electrosurgical excision procedure (LEEP). 2. After Loop Electrosurgical Excision Procedure (LEEP) is performed, obtain low and high resolution optical images before and after applying contrast agents topically to the epithelial surface of the tissue for 30 minutes before rinsing. 3. Submit the specimen for histology, and have it sectioned and stained using both H&E and immunohistochemical staining for EGFR or E6/E7. The images will be reconstructed into a two dimensional map delineating areas of Cervical Intraepithelial Neoplasia (CIN) and of EGFR or E6/E7 overexpression. Maps of the pathology will be compared to those obtained from the intact cervix exposed to the contrast agent.